132 related articles for article (PubMed ID: 26012249)
1. Design, synthesis and in vitro NO-releasing activities of ocotillol-type furoxans.
Bi Y; Yang J; Ma C; Liu ZY; Zhang TT; Zhang XC; Lu J; Meng QG
Pharmazie; 2015 Apr; 70(4):213-8. PubMed ID: 26012249
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, nitric oxide release and antibacterial evaluation of novel nitrated ocotillol-type derivatives.
Bi Y; Yang X; Zhang T; Liu Z; Zhang X; Lu J; Cheng K; Xu J; Wang H; Lv G; Lewis PJ; Meng Q; Ma C
Eur J Med Chem; 2015 Aug; 101():71-80. PubMed ID: 26114813
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and cytotoxic evaluation of nitric oxide-releasing derivatives of isosteviol.
Liu Y; Wang T; Ling Y; Bao N; Shi W; Chen L; Sun J
Chem Biol Drug Des; 2017 Sep; 90(3):473-477. PubMed ID: 28122177
[TBL] [Abstract][Full Text] [Related]
4. The furoxan system: design of selective nitric oxide (NO) donor inhibitors of COX-2 endowed with anti-aggregatory and vasodilating activities.
Del Grosso E; Boschi D; Lazzarato L; Cena C; Di Stilo A; Fruttero R; Moro S; Gasco A
Chem Biodivers; 2005 Jul; 2(7):886-900. PubMed ID: 17193179
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide donor beta2-agonists: furoxan derivatives containing the fenoterol moiety and related furazans.
Buonsanti MF; Bertinaria M; Stilo AD; Cena C; Fruttero R; Gasco A
J Med Chem; 2007 Oct; 50(20):5003-11. PubMed ID: 17845020
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of novel senkyunolide analogues as neuroprotective agents.
Fang Y; Wang R; Wang Q; Sun Y; Xie S; Yang Z; Li M; Jin Y; Yang S
Bioorg Med Chem Lett; 2018 Feb; 28(4):668-672. PubMed ID: 29370975
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of novel NO-releasing furoxan derivatives of aspirin in human platelets.
Turnbull CM; Cena C; Fruttero R; Gasco A; Rossi AG; Megson IL
Br J Pharmacol; 2006 Jun; 148(4):517-26. PubMed ID: 16702997
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents.
Velázquez C; Rao PN; McDonald R; Knaus EE
Bioorg Med Chem; 2005 Apr; 13(8):2749-57. PubMed ID: 15781386
[TBL] [Abstract][Full Text] [Related]
9. Antitumor platinum(II) complexes containing platinum-based moieties of present platinum drugs and furoxan groups as nitric oxide donors: synthesis, DNA interaction, and cytotoxicity.
Zhao J; Gou S; Sun Y; Fang L; Wang Z
Inorg Chem; 2012 Oct; 51(19):10317-24. PubMed ID: 22957695
[TBL] [Abstract][Full Text] [Related]
10. Second generation of alpha-tocopherol analogs-nitric oxide donors: Synthesis, physicochemical, and biological characterization.
López GV; Blanco F; Hernández P; Ferreira A; Piro OE; Batthyány C; González M; Rubbo H; Cerecetto H
Bioorg Med Chem; 2007 Sep; 15(18):6262-72. PubMed ID: 17627828
[TBL] [Abstract][Full Text] [Related]
11. Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: synthesis and evaluation of antihepatocellular carcinoma activity.
Ling Y; Ye X; Zhang Z; Zhang Y; Lai Y; Ji H; Peng S; Tian J
J Med Chem; 2011 May; 54(9):3251-9. PubMed ID: 21504204
[TBL] [Abstract][Full Text] [Related]
12. Syntheses, calcium channel agonist-antagonist modulation activities, and nitric oxide release studies of nitrooxyalkyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(2,1,3-benzoxadiazol-4-yl)pyridine-5-carboxylate racemates, enantiomers, and diastereomers.
Shan R; Velazquez C; Knaus EE
J Med Chem; 2004 Jan; 47(1):254-61. PubMed ID: 14695839
[TBL] [Abstract][Full Text] [Related]
13. Novel Structural Hybrids on the Base of Benzofuroxans and Furoxans. Mini-Review.
Chugunova EA; Burilov AR
Curr Top Med Chem; 2017; 17(9):986-1005. PubMed ID: 27697059
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of furoxan-based nitric oxide-releasing glucocorticoid derivatives with potent anti-inflammatory activity and improved safety.
Fang L; Zhang Y; Lehmann J; Wang Y; Ji H; Ding D
Bioorg Med Chem Lett; 2007 Feb; 17(4):1062-6. PubMed ID: 17129724
[TBL] [Abstract][Full Text] [Related]
15. [Synthesis and anti-inflammatory analgesic activities of phenylfuroxan-coupled diclofenac].
Li RW; Zhang YH; Ji H; Yu XL; Peng SX
Yao Xue Xue Bao; 2002 Jan; 37(1):27-32. PubMed ID: 12579895
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and pharmacological evaluation of novel hybrid compounds to treat sickle cell disease symptoms. part II: furoxan derivatives.
Dos Santos JL; Lanaro C; Chelucci RC; Gambero S; Bosquesi PL; Reis JS; Lima LM; Cerecetto H; González M; Costa FF; Chung MC
J Med Chem; 2012 Sep; 55(17):7583-92. PubMed ID: 22889416
[TBL] [Abstract][Full Text] [Related]
17. [Design, synthesis and antiasthmatic activities of NO-donating seratrodast derivatives].
Zhang ZG; Zhang YH; Ji H; Qiu SG; Feng XC
Yao Xue Xue Bao; 2004 Sep; 39(9):705-10. PubMed ID: 15606018
[TBL] [Abstract][Full Text] [Related]
18. Study of synthesis and cardiovascular activity of some furoxan derivatives as potential NO-donors.
Mu L; Feng SS; Go ML
Chem Pharm Bull (Tokyo); 2000 Jun; 48(6):808-16. PubMed ID: 10866141
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of NO-release from symmetrically substituted furoxans.
Nirode WF; Luis JM; Wicker JF; Wachter NM
Bioorg Med Chem Lett; 2006 Apr; 16(8):2299-301. PubMed ID: 16446086
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel ocotillol-type triterpenoid derivatives as antibacterial agents.
Zhou Z; Ma C; Zhang H; Bi Y; Chen X; Tian H; Xie X; Meng Q; Lewis PJ; Xu J
Eur J Med Chem; 2013 Oct; 68():444-53. PubMed ID: 23994872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
